secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptinyx Inc. (—)
CIK:        0001674365
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001104659-22-125481
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptinyx transfers listing to Nasdaq Capital Market; gets 180-day cure for bid price non-compliance
--------------------------------------------------------------------------------

- Transfer from Nasdaq Global Select to Capital Market effective Dec 9, 2022; stock symbol remains APTX.
- Received additional 180-day period until June 5, 2023 to regain $1.00 minimum bid price compliance.
- Also non-compliant on audit committee composition (needs 3 independent directors) due to Patrick Enright resignation; cure until Nov 30, 2023 or next annual meeting.
- Company may consider reverse stock split to cure bid price deficiency; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674365/000110465922125481/0001104659-22-125481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674365/000110465922125481/tm2232290d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-125481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer